Thomas O. Daniel

Insider Reports History

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, NJ
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas O. Daniel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gossamer Bio, Inc. Director Non-qualified stock option (Right to Buy) 115K Jun 6, 2024 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Jun 28, 2022 Direct
Larimar Therapeutics, Inc. Director Stock Option (right to buy) 8.3K May 12, 2021 Direct

Insider Reports Filed by Thomas O. Daniel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GOSS Gossamer Bio, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
GOSS Gossamer Bio, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
MGTA Magenta Therapeutics, Inc. Jun 28, 2022 1 $0 4 Jun 30, 2022 Director
GOSS Gossamer Bio, Inc. Jun 9, 2022 1 $0 4 Jul 15, 2022 Director
GOSS Gossamer Bio, Inc. Jun 9, 2021 1 $0 4 Jun 10, 2021 Director
MGTA Magenta Therapeutics, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Director
LRMR Larimar Therapeutics, Inc. May 12, 2021 1 $0 4 May 17, 2021 Director